In this episode, Mariam sits down with Jaclyn Levy (she/hers) to talk about her work at AMR Action tackling the unexpected global challenges that COVID-19 brought upon the whole world and why we need to continue investing in the R&D of lifesaving drugs. She also explores the themes of VC funds for social impact and social good in the context of the healthcare industry and different career paths that youth can look into.

Jaclyn Levy is the Director, U.S. Policy at AMR Action Fund, the world’s largest public-private partnership investing in the development of new antimicrobial therapeutics. As Director of the U.S. Policy, she works closely with the Fund’s leadership team and various external stakeholders to support policy solutions and market reforms related to R&D incentives, antimicrobial stewardship, and access.

Prior to working at AMR Action Fund, Jaclyn was a 2020 Atlantic Council Millennium Fellow and Director of Public Policy at the Infectious Diseases Society of America. She has also worked as a biosecurity analyst for the U.S. Department of Homeland Security, scientific editor, and consultant. She has extensive experience in federal and global policy and advocacy work and has authored numerous publications on pandemic preparedness, antimicrobial resistance, molecular diagnostics, and biomedical R&D. Jaclyn is a seasoned communicator and strategist with over a decade of experience in federal and global policy and advocacy work.

Questions? Feedback? Ideas? Contact [email protected]

~~

Subscribe to the Second Day Email Newsletter for social impact jobs, career guides, and other industry news: ⁠⁠https://www.secondday.org/subscribe-now⁠⁠ 

Launch your social impact career with Second Day's resources at ⁠⁠https://www.secondday.org/⁠⁠  

Follow Mariam Matin on 

LinkedIn: ⁠⁠https://www.linkedin.com/in/mariam-matin/⁠⁠ 

Follow Second Day on 

LinkedIn: ⁠⁠https://www.linkedin.com/company/second-day/⁠⁠